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Ground-State Transcriptional Requirements
for Skin-Derived Precursors
Michael T. Suflita,1,2 Elise R. Pfaltzgraff,1,2 Nathan A. Mundell,2,3
Larysa H. Pevny,4 and Patricia A. Labosky1–3,*
Skin-derived precursors (SKPs) are an attractive stem cell model for cell-based therapies. SKPs can be readily
generated from embryonic and adult mice and adult humans, exhibit a high degree of multipotency, and have
the potential to serve as a patient autologous stem cell. The advancement of these cells toward therapeutic use
depends on the ability to control precisely the self-renewal and differentiation of SKPs. Here we show that two
well-known stem cell factors, Foxd3 and Sox2, are critical regulators of the stem cell properties of SKPs. Deletion
of Foxd3 completely abolishes the sphere-forming potential of these cells. In the absence of Sox2, SKP spheres
can be formed, but with reduced size and frequency. Our results provide entry points into the gene regulatory
networks dictating SKP behavior, and pave the way for future studies on a therapeutically relevant stem cell.
Introduction
The extent to which molecular control of pluripotencyand multipotency are conserved across species has re-
ceived considerable attention; less focus has been given to the
degree of conservation between divergent cell types within
a given species. Embryonic stem cells (ESCs) represent the
gold standard for examining mechanisms of pluripotency, yet
progress toward clinical advances remains slow and research
using ESCs is fraught with ethics issues. Induced pluripotent
stem cells may one day function as a suitable replacement, but
the long-term safety of these cells remains unknown. Given
the significant caveats associated with these cells, the contin-
ued development of complementary stem cell models with
potential for stem cell therapies is important. The neural crest
(NC) is an intriguing alternative as a number of the core
pluripotency transcription factors expressed in ESCs are also
expressed in the NC, including Sox2 and Foxd3. Whether
these factors function identically in the NC and in ESCs is
unknown.
Neural crest cells (NCCs) are a highly multipotent cell
type with broad differentiation potential. The NC is specified
in the neurula-stage embryo; these cells undergo an epithelial
to mesenchymal transition and migrate along defined paths
through the embryo. Their fate depends on their rostral-
caudal position of origin in the neural tube, their route of
migration, and final destination (reviewed in [1]). NC defects
result in a number of developmental disorders, including
CHARGE syndrome, Hirschsprung disease, Waardenburg
syndrome, DiGeorge syndrome, congenital heart defects,
and craniofacial abnormalities [2–4]. Cell-based therapies
may be appropriate for some of these syndromes.
Neural crest stem cells (NCSCs) persist through develop-
ment, retaining their multipotency in adult organisms.
NCSCs can be isolated from a number of embryonic and
postnatal derivatives of the NC: dermis of the skin, fetal
peripheral nerves, and the fetal and adult enteric nervous
system [5–9]. Of these, skin-derived precursors (SKPs) are of
particular interest. SKPs are derived from the dermis of ro-
dents and humans, and display a characteristic NC-like gene
signature [9]. SKPs generated from the whisker pads of mice
are NC-derived and can be lineage-labeled using Wnt1-Cre
[10], a transgene expressed throughout the majority of the
NC [11]. In vitro, SKPs exhibit a highly multipotent pheno-
type; they can differentiate into neurons, glia, smooth muscle
cells, adipocytes, osteoblasts, and chondrocytes [9,10,12–16].
The therapeutic efficacy of these cells has been suggested
by rodent transplant studies; undifferentiated SKPs con-
tribute to newly formed bone in a fracture model, ‘‘pre-
differentiated’’ SKPs assist in myelination of nerves in a
sciatic nerve injury model, and these cells may also serve
as an alternative source for cutaneous nerve regeneration
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[12,13,15,17–19]. Importantly, these cells are readily accessi-
ble from adult humans and have the potential to serve as a
patient-autologous stem cell source for a diverse array of
cell-based therapies.
Despite these preclinical advances and the vast knowledge
of transcription factor function in the NC [20], little is known
about the molecules dictating NCSC self-renewal and mul-
tipotency; the ‘‘ground state’’ of these multipotent stem cells
has not been widely explored. Foxd3 and Sox2 are logical
entry points into the genetic regulatory networks governing
SKP behavior. Sox2 expression can be used to prospectively
isolate SKPs in addition to other progenitor cells [6,14,21],
while loss of Foxd3 in the NC causes NC-progenitors to lose
multipotency and self-renewal ability [22,23]. Null mouse
embryos for either Foxd3 or Sox2 have virtually indistin-
guishable phenotypes, with loss of epiblast and an expansion
of extra embryonic tissue, and both proteins are required for
the establishment of ESCs and trophoblast stem cells (TSCs)
[24–26]. Finally, Foxd3 and Sox2 are known to antagonisti-
cally regulate shared loci in ESCs [27]. Given the prominent
role of Sox2 and Foxd3 as key regulators of pluripotency in a
number of stem cell populations, we examined the conse-
quences of a genetic deletion of Sox2 in the NC and in NC-
derived SKPs, and the role of Foxd3 in SKPs.
Materials and Methods
Mouse lines
The Wnt1-Cre transgenic line [28] was used to condition-
ally modify either the Foxd3 conditional allele Foxd3tm3.Lby
(called Foxd3flox here) [23] or the Sox2 conditional allele
Sox2tm2Lpev (called Sox2flox) [29] in combination with the re-
porter allele Gt(ROSA)26Sortm1(EYFP)Cos (called R26RYFP) [30]
to visualize the NC lineage. The Foxd3 null allele Foxd3tm1.Lby
was included in some crosses [25]. The Foxd3 null green
fluorescent protein (GFP) reporter allele Foxd3tm2.Lby (called
Foxd3GFP) [25] was used to visualize Foxd3 expression in
SKPs. The TM inducible transgenic line CAGG Cre-ERTM
(called CreER) [31] was used for conditional deletions of
Foxd3 or Sox2 in SKP cell lines. All mouse lines were main-
tained on a mixed genetic background. All experiments were
carried out in accordance with protocols approved by the
Vanderbilt University Institutional Animal Care and Use
Committee.
Cell culture
ESCs were cultured as described elsewhere [32]. SKPs
were generated and cultured as previously described [9,12].
Briefly, appropriate mice were paired and monitored daily
for the presence of a vaginal plug. Noon on the day of an
observed plug was considered 0.5 days postcoitum (dpc). In
order to generate SKP cultures we used standard methods
[12]. Whisker pads or dorsal back skin were dissected
from 16.5 to 18.5 dpc embryos. Tissues were digested in
0.1% trypsin/ethylenediaminetetraaceticacid for 30–45 min,
mechanically dissociated, and passed through a 40-mM cell
strainer. Single-cell suspensions were plated in Dulbecco’s
modified Eagle’s medium/Ham’s nutrient mixture F12 3:1 in
the presence of 2% B-27 (Invitrogen), 40 ng/mL basic fibro-
blast growth factor (BD Biosciences), and 20 ng/mL epider-
mal growth factor (BD Biosciences). For experiments using
the CreER transgene, a single dose of 0.2 mM
4-hydroxytamoxifen (TM) was added to the culture on day 0.
The TM powder was dissolved in 100% ethanol to make
a 1 mM TM stock solution and stored at - 20C. To quan-
tify the number of SKP spheres, images of cultures were sys-
tematically captured as follows: at least 15 individual
40 · frames of each culture were taken and the number of
spheres per frame was determined. Data are presented as the
average number of spheres per frame. N = 3–5 for each geno-
type. For quantification of SKP sphere size, floating spheres
were collected, pooled, and imaged. Spheres were outlined in
ImageJ and the area was calculated in arbitrary units. At least
65 spheres were counted for each culture. Two-tailed Student’s
t tests were used to determine statistical significance.
Histology
Embryos were fixed in 4% paraformaldehyde overnight
and standard histological procedures used [33]. Antibodies for
immunofluorescence were rabbit-anti-Foxd3 (1:1,000) [26],
goat-anti-Sox2 (1:500; Santa Cruz), and chicken-anti-GFP
(1:500; Abcam). Secondary antibodies were from Jackson Im-
munoResearch and 4¢,6-diamidino-2-phenylindole (1:2,000;
Molecular Probes) was used to visualize cell nuclei. Images
were captured on either a Nikon Eclipse E600 or a Zeiss Ax-
ioCam MRc, both using Qcapture software. For quantification
of dorsal root ganglia (DRG) size, serial sections of three pairs
of DRGs at the level of the cardiac NC were examined for each
genotype. DRGs were outlined using ImageJ software and
the area calculated in arbitrary units. N = 2 embryos for each
genotype.
Quantitative real-time polymerase chain reaction
Total RNA was harvested from established SKP lines us-
ing the RNeasy Mini Kit (Qiagen) and genomic DNA re-
moved using Turbo DNase (Ambion). cDNA was prepared
using the GoScriptTM Reverse Transcription System (Pro-
mega) and quantitative real-time polymerase chain reaction
(qRT-PCR) performed using the GoTaq qPCR Master Mix
(Promega) and analyzed on an Applied Biosystems 7900




Sox2, 5¢-GAGGAAAGGGTTCTTGCTGGGTTT-3¢ and 5¢-GGT
CTTGCCAGTACTTGCTCTCAT-3¢. Expression is presented
as the difference in threshold cycle number of the transcript of
interest relative to Gapdh.
Results
Sox2 and Foxd3 expression in NCCs
and NCSCs/SKPs
The function of Sox2 in the NC has been largely over-
looked. Early reports using in situ hybridization failed to
detect Sox2 mRNA in NCCs [34]. However, several recent
reports described roles for Sox2 in controlling the behavior of
NC stem and progenitor cells: Sox2 maintains the progenitor
status of NCCs fated to become melanocytes [35], and ex-
pression of Sox2 in the NC is essential for peripheral neu-
rogenesis [36]. Given these recent findings, we re-examined
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the expression of Sox2 using more sensitive immunofluo-
rescence techniques in combination with an NC-specific lin-
eage label.
Sox2 protein is detected as early as 8.5 days dpc in pre-
migratory and migratory cranial NCCs (Fig. 1A, B). This NC
expression pattern is nearly indistinguishable from that of
Foxd3 (Fig. 1C), a factor with established roles in the NC in
multiple model systems [22,23,37–40]. At 9.5 dpc, Sox2 is
expressed at a low level in trunk NCCs as they emigrate
from the neural tube (Fig. 1D, E). At 12.5 dpc, Foxd3, and
Sox2 are co-expressed in the DRG, an NC-derived structure
[41]. Our observations of Sox2 expression in the DRG are
consistent with other reports [36,42].
SKPs are derived from the dermal papillae of mouse hair
and whisker follicles [10], and can be prospectively isolated
based on Sox2 expression [14]. Although Foxd3 expression
has been reported in SKPs [43], it was unknown whether
Foxd3 is expressed in the endogenous stem cell niche. Using
immunofluorescence, at 12.5 dpc Sox2 was expressed in the
NC-derived dermal condensates preceding whisker follicle
morphogenesis (Fig. 2A–C). Foxd3 protein was localized to
the periphery of the dermal condensates and was co-
expressed with Sox2 (Fig. 2A, B, and D). At 17.5 dpc, an age
when SKPs are readily generated, Sox2 is expressed in two
distinct populations: (1) the NC-derived dermal papilla and
dermal sheath, and (2) a non-NC lineage that was previously
described as diagnostic of Merkel cells [44]. In contrast,
Foxd3 is expressed exclusively in the NC lineage (Fig. 2E). It
is not present in the dermal papilla, but was detected more
distally in the whisker follicle, where it was co-expressed
with Sox2. In cranial NC mesenchyme Foxd3 is expressed
independently of Sox2 (Fig. 2F).
These results suggest the expression of Foxd3 is initiated
during SKP establishment and is not present in the progenitors
in vivo. To confirm this, Foxd3 expression was visualized in
SKPs using a Foxd3GFP allele that has been used for this pur-
pose in other contexts and faithfully represents the endoge-
nous express of the locus in all contexts tested [45,46] (Fig. 3A,
B). This was confirmed by analyzing Foxd3 transcripts in SKPs
using qRT-PCR (Fig. 3C), consistent with previous reports [43].
As a positive control, qRT-PCR was used to show similar
levels of Foxd3 transcripts in ESCs, a cell type that requires
Foxd3 for self-renewal and inhibition of differentiation [32].
The expression of Sox2 and Foxd3 in NCCs is consistent with
the notion that these two transcription factors function in
NCSCs. Sox2 and Foxd3 are critical factors in multiple stem
cell populations, but their role in NCSCs, and the role of Sox2
in the NC, had not been examined.
A Wnt1-Cre-driven deletion of Sox2 results
in perinatal death, but causes minimal
morphological defects
The role of Foxd3 in the NC has been extensively studied;
however, the function of Sox2 in the NC is largely unknown.
We used Wnt1-Cre to drive deletion of Sox2 in the NC. In
contrast to previous reports that showed embryonic lethality
of these animals [36], mice derived from a Wnt1-Cre-driven
deletion of Sox2 were born alive (n = 4). However, these mice
did not survive beyond 2 days. Sox2flox/flox; Wnt1-Cre em-
bryos had no detectable abnormalities in their craniofacial
skeletons, nor did they exhibit any congenital heart defects
(data not shown). As a potential cause of death, diaphragms
were examined for proper innervation. At 16.5 dpc, no
FIG. 1. Sox2 and Foxd3 are expressed in NCCs. (A) Whole-mount bright-field image of an 8.5 dpc embryo. Lines represent
the plane of section in B and C. (B) Sox2 (magenta) is expressed in cranial NCCs at 8.5 dpc as indicated by co-expression with
the Wnt1-Cre activated YFP lineage label (green). White arrows highlight several co-expressing cells (200 · ). (C) Foxd3 (ma-
genta) expression in cranial NCCs, again white arrows indicate co-expressing cells (200 · ). (D, E) Sox2 (magenta) is expressed at
low levels in trunk NCCs at 9.5 dpc as the cells are exiting the neural tube (white arrows). (E) Shows the Sox2 channel alone.
Magenta arrows indicate Sox2 expressing NC cells. Note, the Sox2 expression in the NC is markedly lower than that observed
in the neural tube (400 · ). (F) Foxd3 (green) and Sox2 (magenta) are co-expressed in trunk DRG of a 12.5 dpc embryo (400 · ).
NCCs, neural crest cells; dpc, days post coitum; DRG, dorsal root ganglion; NC, neural crest; nt, neural tube. Color images
available online at www.liebertpub.com/scd
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defects were seen with the innervation of Sox2flox/flox; Wnt1-Cre
diaphragms as visualized by PGP9.5 immunolocalization to
mark neurons. In both Sox2flox/flox; Wnt1-Cre embryos and Sox2wt/
wt; Wnt1-Cre littermate controls the phrenic nerves ranged the
length of the diaphragms, extending to the proximal and distal
tips, with numerous secondary branches (Fig. 4A, B). These data
suggested that the cause of death is likely not due to respiratory
defects. In addition to the NC, the Wnt1-Cre transgene is ex-
pressed in the developing midbrain and dorsal neural tube, both
areas of robust Sox2 expression [28]. Thus, the cause of death may
be due to neural tube defects, but at this time remains undeter-
mined. Consistent with a previous report [36] Sox2 expression
was absent in the DRGs of 16.5 dpc Sox2flox/flox; Wnt1-Cre embryos
(Fig. 4C, D). We also observed a 47% reduction in the area of
the DRGs with a 2.36% standard error of the mean change, n = 3
(Fig. 4E, F), again consistent with previous reports [36].
SKPs can be established without Sox2,
but at a significantly reduced frequency
While SKPs can be prospectively isolated based on Sox2
expression [14], the requirement for Sox2 in SKPs had not been
investigated. SKPs generated from whisker pads of mice are
derived from NC and therefore are lineage labeled with the
Wnt1-Cre transgene [10]. This Cre was used to determine the
requirement for Sox2 in the establishment of SKPs.
First, to confirm Sox2 was deleted in the endogenous SKP
niche, whisker pads were examined from 17.5 dpc Sox2flox/flox;
Wnt1-Cre embryos. Sox2 was no longer detected in the
NC-derived portion of the whisker follicle (Fig. 5E), although
Sox2 expression was unchanged in the non-NC portion. We
observed no qualitative differences in the morphology of the
follicles at a macroscopic or histological level. Co-expression
of Sox2 and Foxd3 was completely lost in Sox2flox/flox; Wnt1-
Cre whisker pads (Fig. 5F). SKPs generated from whisker
pads of Sox2flox/flox; Wnt1-Cre embryos were modestly
reduced in number compared to littermate controls; this
difference was not statistically significant (Fig. 6A–D, quan-
tified in Fig. 6E). Sox2 transcripts were reduced *14-fold in
Sox2flox/flox; Wnt1-Cre SKPs compared to Sox2wt/wt; Wnt1-Cre
littermate control SKPs (Fig. 6F). To extend this line of
investigation, we used a TM inducible CreER to condition-
ally delete Sox2 from SKPs during establishment of the cul-
tures. Cells from Sox2flox/flox; CreER embryos treated with a
single dose of 0.2mM TM on day 0 of culture resulted in
an 66% reduction in the number of spheres compared to
untreated Sox2flox/flox; CreER cells from the same embryo
(Fig. 6G–K). TM treatment of cells from Sox2flox/flox embryos
lacking the inducible Cre transgene showed no difference in
the number of spheres generated compared to untreated cells
from the same embryo. Additionally, spheres derived from
TM-treated Sox2flox/flox; CreER cells were reduced in size by 72%
FIG. 2. Sox2, but not Foxd3, is expressed in the endogenous SKP niche. (A) At 12.5 dpc, Sox2 (red) is expressed in the dermal
condensates preceding whisker follicle morphogenesis. Foxd3 (blue) is expressed on the periphery of the dermal condensates
(blue arrow). Expression of both proteins is restricted to the NC lineage (green). (200 · ). (B–D) Panels show the individual
channels. Foxd3 (blue) is co-expressed with Sox2 (red) ( purple arrow) (200 · ). (E) At 17.5 dpc, Sox2 (red) is expressed in two
distinct lineages: the NC in the dp (yellow arrow) and non-NC surrounding the more proximal part of the whisker follicle (red
arrow). Foxd3 (blue) is only expressed in the NC lineage (100 · ). (F–H) Panels show the individual channels. In the whisker
follicle Foxd3 (blue) is co-expressed with Sox2 (red) in the NC-derived cells ( purple arrow). In the mesenchyme, Foxd3 is
expressed in cells that do not express Sox2 (blue arrow) (100 · ). SKPs, skin-derived precursors; dp, dermal papilla. Color
images available online at www.liebertpub.com/scd
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compared to untreated cells from the same embryo (Fig. 6L).
These results demonstrate that SKPs are able to form in the
absence of Sox2, but do so at a significantly reduced capacity.
Foxd3 is required for the establishment of SKPs
Foxd3 is one of the earliest markers of NC [37,38,40,47–50]
and its role in NC maintenance has been well documented
[22,23,38,51]; however, its role in NCSC/SKPs was unknown.
As described above for Sox2, we tested the requirement for
Foxd3 in establishment of SKPs. In control embryos heterozy-
gous for Foxd3, all SKPs were derived from NC as shown using
the Wnt1-Cre; R26RYFP lineage-label (Fig. 7A–C). In contrast,
although numerous spheres were formed from whisker pads of
Foxd3flox/flox; Wnt1-Cre embryos (Fig. 7D–F), none of the re-
sulting spheres were derived from NC, evidenced by a lack of
FIG. 4. Sox2flox/flox; Wnt1-Cre embryos showed normal innervation of the diaphragm, but reduced DRG size. (A, B) PGP9.5 (green)
staining revealed no difference in the innervation of the diaphragm at 16.5 dpc in control versus Sox2flox/flox; Wnt1-Cre embryos,
suggesting that respiratory defects are not the cause of death for theSox2flox/flox; Wnt1-Cre mice. The white box denotes the area
shown in higher magnification at the bottom of the panel (100 · composite, inset 400 · ). (C, D) Sox2 protein (red) was present in the
DRGs of 16.5 dpc control embryos, but not detectable in the DRGs of Sox2flox/flox; Wnt1-Cre littermates. DRGs are outlined in white
(200 · ). (E, F) Hematoxylin and eosin (H&E) staining revealed DRGs from Sox2flox/flox; Wnt1-Cre 16.5 dpc embryos are reduced in
size compared to controls, DRGs are outlined in black (200 · ). Color images available online at www.liebertpub.com/scd
FIG. 3. Foxd3 is expressed in SKPs. (A, B) Bright-field and fluorescent images of SKPs carrying the Foxd3GFP allele (200 · ).
(C) Foxd3 transcripts were detected by quantitative real-time-polymerase chain reaction in SKPs. Foxd3 transcript levels in
embryonic stem cells (ESCs) are included for comparison. Color images available online at www.liebertpub.com/scd
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YFP-positive spheres (Fig. 7E). Additionally, Foxd3 transcripts
were detected at levels comparable to littermate controls
(Fig. 7G). These data suggest that when Foxd3 is deleted, NC-
derived SKPs are not established, yet spheres were generated
from an as-yet-unidentified non-NC source.
To test the requirement for Foxd3 in the establishment of
SKPs independently, SKPs were generated from Foxd3flox/flox;
CreER embryos. A single dose of 0.2mM TM completely abol-
ished the sphere-forming potential of these cells (Fig. 7H, I),
while untreated cells and Foxd3flox/flox cells lacking the inducible
Cre transgene treated with 0.2mM TM behaved identically to
control cells (Fig. 7G). These results indicate that Foxd3 is re-
quired for establishment of SKP cultures.
Discussion
Sox2 and Foxd3 are key regulators of pluripotency and
multipotency in several different stem cell populations [24–
26]. Our findings suggest these factors function in a similar
manner in NCSCs. As with ESCs and TSCs there is an ab-
solute requirement for Foxd3 in the establishment of SKP cell
lines. We found that SKP spheres are formed in the absence
of Sox2, but at a severely diminished frequency.
Given the robust expression of Sox2 in the endogenous
SKP niche, and the apparent absence of Foxd3 in the dermal
papilla, it is somewhat surprising that deletion of Foxd3 from
SKPs exhibits a more robust phenotype. Foxd3 is one of the
earliest markers of the NC. Expression of Foxd3 is highest in
uncommitted NC stem and progenitor cells, and is dimin-
ished as cells lose multipotency and differentiate [47,49]. Our
observation that Foxd3 expression must be re-acquired in
order to establish SKP cultures further confirms its role as a
key factor controlling stem cell behavior.
There are a number of possibilities to explain the differ-
ences we describe between deletion of Sox2 with the Wnt1-
Cre versus the CreER transgene. Sox2 is a prospective marker
of SKP progenitor cells [14], yet in Sox2flox/flox; Wnt1-Cre
embryos, a population of Sox2-expressing cells remains in
the whisker follicle. It is currently unknown whether these
cells outside the NC are able to contribute to SKP formation.
Additionally, SKP spheres are isolated by serial transfer of
the floating spheres from the underlying adherent popula-
tion of cells. However, these adherent cells are always re-
established at each passage. The relationship between these
support cells and SKPs is not understood and there could be
a requirement for Sox2 in the support cells. These cells might
not be targeted using the Wnt1-Cre and Sox2 might retain
functionality in these cultures. The more dramatic phenotype
seen with Sox2flox/flox; CreER SKPs could account for both
these possibilities. Alternatively, the difference could be due
FIG. 5. Sox2-expressing cells remain in whisker follicles of Sox2flox/flox; Wnt1-Cre embryos. (A–D) Sox2 (red), Foxd3 (blue), and
YFP (green) expression in a control 17.5 dpc whisker pad. Red arrow indicates Sox2 expression outside the NC, yellow arrow
indicates Sox2 expression in the NC lineage. Foxd3 is expressed in the NC and co-expressed with Sox2 (magenta arrow) (100 · ).
(E–H) In Sox2flox/flox; Wnt1-Cre embryos, Sox2 (red) expression is lost in the NC lineage (white arrow). Outside the NC, Sox2
expression is unchanged. Foxd3 (blue) and Sox2 (red) are no longer co-expressed in the NC lineage. Red arrow indicating a cell
expressing Sox2, blue arrow indicating a cell expressing Foxd3 (100 · ). Color images available online at www.liebertpub.com/scd
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to the timing of deletion of Sox2. Sox2 is deleted much earlier
in the embryo using the Wnt1-Cre as opposed to the CreER,
and it is possible the SKP precursor cells have sufficient time to
compensate for the loss of Sox2 while still in the embryo.
A unique feature of SKPs is that these transcriptionally
similar stem cells can be generated from divergent embry-
onic origins: NC in the facial dermis versus mesoderm in the
dorsal skin [43,52]. Recent work demonstrated that meso-
dermally derived SKPs are able to generate Schwann cells in
vitro, a cell type thought to be exclusively derived from the
NC [53]. Our findings are consistent with the possibility that
cells of mesodermal origin may compensate for the lack of
NC precursors in Foxd3flox/flox; Wnt1-Cre embryos in vivo.
Given the size, importance, and highly regenerative nature of
the skin, it is perhaps not surprising that multiple mecha-
nisms exist to generate the multipotent progenitor cell types
in the skin.
In ESCs, Sox2 and Foxd3 regulate several shared loci, with
Sox2 maintaining DNA in an open chromatin conformation,
while Foxd3 actively represses transcription of these shared
target genes [27]. This antagonistic relationship is hypothe-
sized to keep target genes in a poised state, able to respond
to differentiation cues in a rapid manner. It is currently
unknown whether this relationship is conserved in NC
progenitors or in SKPs. In fact, little direct regulatory infor-
mation exists regarding the gene regulatory networks of
NC and NCSCs. SKPs provide an abundant cell source for
addressing these questions.
FIG. 6. Deletion of Sox2 results in reduced sphere forming potential. (A, B) Bright-field and fluorescent images of SKPs derived
from the whisker pads of a 17.5 dpc control embryo (40 · ). (C, D) SKPs derived from Sox2flox/flox; Wnt1-Cre embryos are NC-
derived and modestly reduced in number (40 · ). (E) Quantification of the number of spheres formed when Sox2 is deleted with
Wnt1-Cre (P = 0.29). (F). Sox2 transcripts were reduced *14-fold in Sox2flox/flox; Wnt1-Cre SKPs as compared to littermate controls.
This difference is statistically significant (*P < 0.05). (G–J) Inducible deletion of Sox2. In (F) and (G) a control cell line shows no
difference in sphere forming potential when treated with TM. When the cell line carrying the inducible Cre transgene is treated
with TM to delete Sox2 we observed a significant reduction in the number of spheres (40 · ). (K) Quantification of the number of
spheres formed when Sox2 is deleted using TM to activate the CreER transgene (*P < 0.05). Data is presented in average number
of spheres per area. (L) Quantification of the average sphere area from Sox2flox/flox; CreER untreated and TM treated cultures. Data
are presented in arbitrary units (*P < 0.05). TM, tamoxifen. Color images available online at www.liebertpub.com/scd
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Conclusion
Being able to effectively control the self-renewal, prolif-
eration, and differentiation of SKPs is key to advancing these
cells toward clinical use. Toward this goal, we have dem-
onstrated here that two well-known stem cell proteins, Foxd3
and Sox2, are important regulators of the stem cell properties
of SKPs. This study provides the framework to move forward
our understanding of the molecular controls of self-renewal
and multipotency in a potentially therapeutic stem cell.
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